市场调查报告书
商品编码
1287529
单细胞多组学市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Single Cell Multiomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
全球单细胞多组学市场规模在2022年达到34亿美元。展望未来,IMARC集团预计到2028年,市场规模将达到91亿美元,在2023-2028年期间表现出17.6%的增长率(CAGR)。
单细胞多组学是指对单个细胞的多种类型的分子进行分析,以获得有关细胞多样性和异质性的洞察力。它涉及单细胞基因组学、蛋白质组学、转录物组学和代谢组学,广泛用于神经学、免疫学、细胞生物学和肿瘤学。单细胞多组学有助于加强对异质组织的群体结构和细胞特性的理解。它利用单细胞分离和分配技术来提供分子层和复杂生物结构的图像。与传统使用的活细胞荧光成像技术相比,单细胞多组学不涉及破坏细胞进行分析,并能从一个细胞测量多种类型的分子。因此,它被广泛用于整个生物技术和制药组织、医院、学术和研究机构以及诊断实验室。
癌症和传染性病毒疾病等慢性疾病的发病率上升,是推动市场增长的关键因素之一。单细胞多组学提供了肿瘤中细胞成分的高分辨率景观。此外,广泛采用产品对细胞异质性、肿瘤微环境和抗体发展进行可视化和分析,有利于市场增长。此外,各种技术进步,如单细胞分离和条形码技术的发展,使脱氧核糖核酸(DNA)、信使核糖核酸(mRNA)和蛋白质概况可以在单细胞分辨率下测量,正在为市场增长提供推动力。与此相呼应,制药业的大幅增长对市场增长产生了积极的影响。其他因素,包括越来越多地采用个性化医疗来治疗遗传性疾病,以及医疗基础设施的广泛改善,预计将推动市场的增长。
The global single cell multiomics market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2028, exhibiting a growth rate (CAGR) of 17.6% during 2023-2028.
Single cell multiomics refers to the analysis of multiple types of molecules from an individual cell to gain insights regarding cellular diversity and heterogenity. It involves single cell genomics, proteomics, transcriptomics and metabolomics and is widely used in neurology, immunology, cell biology and oncology. Single cell multiomics aids in enhancing the understanding of population architectures and cellular properties of heterogeneous tissues. It utilizes single cell isolation and dispensing techniques to provide images of the molecular layers and complex biological structures. In comparison to the traditionally used live-cell fluorescence imaging techniques, single-cell multi-omics does not involve the destruction of cells for analysis and can measure multiple types of the molecule from a single cell. As a result, it is widely used across biotechnology and pharmaceutical organizations, hospitals, academics and research institutes and diagnostic laboratories.
The rising prevalence of chronic diseases, such as cancer and communicable viral diseases, is one of the key factors driving the growth of the market. Single cell multiomics provides a high-resolution landscape of cellular components in the tumors. Additionally, the widespread product adoption for visualization and analysis of cell heterogeneity, tumor micro-environment and antibody development are favoring the market growth. Moreover, various technological advancements, such as the development of single-cell isolation and barcoding technologies that enable deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA) and protein profiles to be measured at a single-cell resolution, are providing a thrust to the market growth. In line with this, significant growth in the pharmaceutical industry is positively impacting the market growth. Other factors, including the increasing adoption of personalized medicine for the treatment of genetic disorders, along with the extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single cell multiomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product type, technique, application and end user.
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
Consumables
Instruments
Software
Single-Cell Isolation and Dispensing
Single-Cell Analysis
Oncology
Cell Biology
Neurology
Others
Academic Institutes
Contract Research Organizations
Pharmaceutical and Biotech Companies
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global single cell multiomics market in 2022?
2. What is the expected growth rate of the global single cell multiomics market during 2023-2028?
3. What has been the impact of COVID-19 on the global single cell multiomics market?
4. What are the key factors driving the global single cell multiomics market?
5. What is the breakup of the global single cell multiomics market based on the type?
6. What is the breakup of the global single cell multiomics market based on the product type?
7. What is the breakup of the global single cell multiomics market based on the technique?
8. What is the breakup of the global single cell multiomics market based on the application?
9. What is the breakup of the global single cell multiomics market based on the end user?
10. What are the key regions in the global single cell multiomics market?
11. Who are the key players/companies in the global single cell multiomics market?